Ming-Sound Tsao
Affiliations: | Medical Biophysics | University of Toronto, Toronto, ON, Canada |
Area:
Oncology, Molecular Biology, Cell Biology, General BiophysicsGoogle:
"Ming-Sound Tsao"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ran X, Wu BX, Shi M, et al. (2023) CRISPR screen of druggable targets in small cell lung cancer identified ATM inhibitor (AZD1390) as a radiosensitizer. International Journal of Radiation Oncology, Biology, Physics |
| Dacic S, Travis W, Redman M, et al. (2023) International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Ji L, Moghal N, Zou X, et al. (2022) The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells. Cancer Medicine |
| Garcia-Pardo M, Czarnecka K, Law JH, et al. (2022) Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy. Therapeutic Advances in Medical Oncology. 14: 17588359221126151 |
| Mirhadi S, Tam S, Li Q, et al. (2022) Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes. Nature Communications. 13: 1811 |
| Perdrizet K, Stockley TL, Law JH, et al. (2022) Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare system. Cancer Treatment and Research Communications. 31: 100534 |
| Melosky B, Cheema P, Juergens RA, et al. (2021) The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 13: 17588359211056306 |
| Saraon P, Snider J, Schormann W, et al. (2021) Chemical genetics screen identifies COPB2 tool compounds that alters ER stress response and induces RTK dysregulation in lung cancer cells. Journal of Molecular Biology. 167294 |
| Cheung CC, Smith AC, Albadine R, et al. (2021) Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 160: 127-135 |
| Melosky B, Wheatley-Price P, Juergens RA, et al. (2021) The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands) |